Probiotic therapy for newborns
    2.
    发明申请
    Probiotic therapy for newborns 有权
    新生儿益生菌治疗

    公开(公告)号:US20010036453A1

    公开(公告)日:2001-11-01

    申请号:US09780841

    申请日:2001-02-09

    申请人: UREX BIOTECH INC.

    IPC分类号: A61K045/00

    摘要: The invention relates to probiotic microbes, including but not limited to Lactobacillus species and Bifidobacteria species, and their compositions and methods of employing said compositions for treating and preventing intestinal and other infections which originate from the intestine, in newborn infants. The invention also invention relates to the ability of probiotic organisms, either in viable or nonviable state, or their by-products, to interfere with pathogenic infection through short and long term colonization of the intestine, inhibition of growth of the pathogens, and assisting the host to fight off the infecting organisms.

    摘要翻译: 本发明涉及益生菌微生物,包括但不限于乳杆菌属物种和双歧杆菌物种,以及它们在新生儿中使用所述组合物用于治疗和预防源于肠道的肠道和其它感染的组合物和方法。 本发明还涉及益生菌生物在活的或不可行的状态或其副产物中通过短期和长期肠道定殖干扰病原体感染的能力,抑制病原体的生长,以及协助 主持人打击感染生物。